Literature DB >> 32583344

Failure of Cardiovascular Phase 3 Randomized Clinical Trials to Report Pre-trial and Post-trial Parameters: a Cross-sectional Analysis of ClinicalTrials.gov.

Alexander R Zheutlin1, Joshua D Niforatos2, Eric Stulberg1, Jeremy B Sussman3.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32583344      PMCID： PMC8175522          DOI： 10.1007/s11606-020-05995-9

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   6.473


× No keyword cloud information.
  5 in total

1.  Underpowering in randomized trials reporting a sample size calculation.

Authors:  Andrew J Vickers
Journal:  J Clin Epidemiol       Date:  2003-08       Impact factor: 6.437

2.  Sample size calculations in randomised trials: mandatory and mystical.

Authors:  Kenneth F Schulz; David A Grimes
Journal:  Lancet       Date:  2005 Apr 9-15       Impact factor: 79.321

3.  Research Waste in Randomized Clinical Trials: a Cross-Sectional Analysis.

Authors:  Alexander R Zheutlin; Joshua Niforatos; Eric Stulberg; Jeremy Sussman
Journal:  J Gen Intern Med       Date:  2019-11-12       Impact factor: 5.128

Review 4.  Data sharing and reanalysis of randomized controlled trials in leading biomedical journals with a full data sharing policy: survey of studies published in The BMJ and PLOS Medicine.

Authors:  Florian Naudet; Charlotte Sakarovitch; Perrine Janiaud; Ioana Cristea; Daniele Fanelli; David Moher; John P A Ioannidis
Journal:  BMJ       Date:  2018-02-13

Review 5.  Reporting of sample size calculation in randomised controlled trials: review.

Authors:  Pierre Charles; Bruno Giraudeau; Agnes Dechartres; Gabriel Baron; Philippe Ravaud
Journal:  BMJ       Date:  2009-05-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.